WOODBRIDGE, N.J., March 28,
2023 /PRNewswire/ -- Miku Care (Miku), the
technology company that revolutionized the pediatric wellness space
using a contactless respiratory & sleep monitoring system,
announced today that it has been selected to join The West Coast
Consortium for Technology & Innovation in Pediatrics (CTIP), a
pediatric medical device accelerator centered at Children's
Hospital Los Angeles (CHLA) and the University
of Southern California (USC)
that promotes the commercialization and clinical use of pediatric
medical device technology.
"We are honored to be recognized by CTIP and earn a place
alongside some of the world's most innovative healthcare
companies," said Johann Fernando,
Ph.D., Chief Executive Officer at Miku Care. "Through this
partnership with CTIP, Miku gains a strong ally equally dedicated
to innovation and development of pediatric medical devices."
Miku Care is currently designed for parents and caregivers,
offering a sleep monitoring solution that comes with intuitive
displays and analytics that make it easy for parents to understand
their child's sleep and respiratory behaviors and trends, all
without the use of a wearable accessory. Miku is not currently
offered or intended for diagnostic use.
Miku's wearable-free monitoring technology has the potential to
reduce usage issues and monitoring obstructions by eliminating the
need for wearing, charging, or cleaning a wearable product. Beyond
wearables, SensorFusion® technology also has the potential to
overcome the challenges of existing camera-only or under-mattress
products. In scenarios with blankets, obstructions, and shadows in
a crib or bed of any size, Miku continues to provide monitoring
coverage for caretakers.
"Pediatric medical device innovation lags behind adults by 10-15
years—this is a major inequity in healthcare. CTIP is committed to
addressing this by identifying and supporting the development of
potential pediatric medical devices by innovators like Miku from
concept to commercialization," said Dr. Juan Espinoza, Director and Principal
Investigator at CTIP.
In 2022, Miku Care in collaboration with Boston Children's
Hospital announced a first-of-its-kind epilepsy research study
using an investigational monitoring device. This research aims to
monitor and ultimately detect generalized tonic-clonic seizures,
which occur in 25% of all patients with seizures and are the most
common type of generalized seizure in adults. These seizures are
also a major risk factor for sudden unexpected death in epilepsy
(SUDEP). The Institutional Review Board (IRB)-approved study aims
to capture generalized tonic-clonic seizure events on study
participants. Patients will be monitored by Miku Care's
SensorFusion® technology, and simultaneously, a video-EEG system,
the industry-regarded "gold standard" of hospital monitoring.
The study is currently underway, providing hope to parents and
caregivers of loved ones. With this research, Miku aims to gain
insight into detecting generalized tonic-clonic seizures in a home
setting using its contact-free sensing technology, as well as the
ability to predict seizure activity before it occurs based on
longitudinal wellness trends in respiration, heart rate, and sleep,
combined with the patient's history of seizures. The data collected
is intended to advance the health and wellbeing of children and
support a potential marketing application.
"Our dedicated team at Miku has spent years focusing on
developing innovative technologies to advance pediatric care," said
Eric White, Co-founder and Chief
Product & Technology Officer at Miku Care. "We are excited to
partner with CTIP and believe that by working together we will
create and expand opportunities as well as lead future
developments."
To learn more, visit https://mikucare.com/.
About The West Coast Consortium
for Technology & Innovation in Pediatrics (CTIP)
The West Coast Consortium for Technology & Innovation in
Pediatrics (CTIP) is an FDA-funded pediatric MedTech accelerator
centered at Children's Hospital Los Angeles. Our goal is to
facilitate the development, production, and distribution of
pediatric medical devices by identifying companies working in the
space and providing advice, networking, and direct and indirect
financial support on the road to commercialization. Learn more at
https://www.westcoastctip.org/
About Miku Care
Miku Care is a pediatric health monitoring company creating
products that make it easy for parents to understand their child's
sleep and respiratory behaviors and trends. The contact-free Miku
Pro Smart Baby Monitor and corresponding analytics platform give
parents easy access to breathing and sleep data, all without the
use of a wearable. Miku smart baby monitors are currently not
offered or intended to diagnose, cure, mitigate, prevent, or treat
any illness or condition and are not approved or cleared by
FDA.
Founded in 2018, Miku Care's products and proprietary,
clinically tested SensorFusion™ technology have received
accolades from Fast Company, CES, Good Housekeeping, Babylist,
Digital Trends, and more for innovation, design, and overall
industry best-of. Partnered with established universities, hospital
systems, research organizations, investors, and leaders, Miku is
pioneering contactless monitoring in the pediatric space. For more
information, please visit mikucare.com. Follow us
on Instagram, Facebook, Twitter and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/miku-care-selected-to-join-the-west-coast-consortium-for-technology--innovation-in-pediatrics-ctip-301782930.html
SOURCE Miku